耐甲氧西林金黄色葡萄球菌感染性肺炎中医药研究概况  

Research Overview of TCM on Methicillin-resistant Staphylococcus Aureus Pneumonia

作　　者：钱家骅[1] 鹿振辉[1] 张惠勇[1] QIAN Jia-hua;LU Zhen-hui;ZHANG Hui-yong(Pneumology Department, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China)

机构地区：[1]上海中医药大学附属龙华医院肺病科,上海200032

出　　处：《中国中医药信息杂志》2017年第12期129-132,共4页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：国家自然科学基金(81403353);上海市中医药事业发展三年行动计划(ZY3-CCCX-2-1002)

摘　　要：耐甲氧西林金黄色葡萄球菌(MRSA)已成为医院内肺部感染的重要致病菌。近年来,中医药在MRSA感染性肺炎的治疗中发挥着积极的作用,疗效确切。本文对该领域研究概况进行综述,为MRSA感染性肺炎的临床治疗及后续研究提供参考。Methicillin-resistant staphylococcus aureus(MRSA)has become an important pathogen of nosocomial pulmonary infection.In recent years,TCM is found to be effectivein the treatment of MRSA pneumonia,with confirmed efficacy.This article reviewed the research of TCM on MRSA pneumonia,providing references for clinical treatment of MRSA pneumonia and further study.

关 键 词：耐甲氧西林金黄色葡萄球菌 肺炎 中医药 综述 

分 类 号：R256.1[医药卫生—中医内科学]